Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Wiener Medizinische Wochenschrift (1946)|December 10, 2009
[How to use PSA in 2009]Anton Ponholzer, Franz Stoiber, Wolfgang Loidl, et al.
Anticancer Research|March 9, 2012
Sentinel lymphadenectomy compared to extended lymphadenectomy in men with prostate cancer undergoing prostatectomyAnton Ponholzer, Michael Lamche, Max Klitsch, et al.
Anticancer Research|July 2, 2010
Proposal for a standardized PSA doubling-time calculationAnton Ponholzer, Nikolaus Popper, Felix Breitenecker, et al.
The Journal of Urology|May 19, 2007
A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancerMichael Krainer, Sandra Tomek, Katarzyna Elandt, et al.
Oncology|April 12, 2017
Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder CancerDora Niedersüss-Beke, Thomas Puntus, Thomas Kunit, et al.
World Journal of Urology|February 11, 2014
Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional studyAnton Ponholzer, Sophina Trubel, Paul Schramek, et al.
World Journal of Urology|September 25, 2013
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancerMalte Rieken, Luis A Kluth, Evanguelos Xylinas, et al.
Urologic Oncology|September 24, 2013
Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?Luis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
BJU International|September 24, 2013
Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasisNiccolo M Passoni, Harun Fajkovic, Evanguelos Xylinas, et al.
Clinical Genitourinary Cancer|October 22, 2016
The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among CliniciansThomas Martini, Christian Gilfrich, Roman Mayr, et al.
Pageof 3